Enovix Corporation (NASDAQ:ENVX - Get Free Report)'s share price was down 8.1% during trading on Tuesday . The stock traded as low as $5.32 and last traded at $5.2850. Approximately 1,862,193 shares were traded during trading, a decline of 70% from the average daily volume of 6,281,965 shares. The stock had previously closed at $5.75.
Analyst Upgrades and Downgrades
Several research firms have issued reports on ENVX. Oppenheimer reiterated an "outperform" rating on shares of Enovix in a research report on Thursday, February 26th. Wells Fargo & Company set a $6.00 price objective on Enovix in a research report on Thursday, March 12th. Craig Hallum cut their price objective on Enovix from $16.00 to $10.00 and set a "buy" rating for the company in a research report on Thursday, February 26th. B. Riley Financial cut their price objective on Enovix from $17.00 to $10.00 and set a "buy" rating for the company in a research report on Monday, March 2nd. Finally, Canaccord Genuity Group cut their price objective on Enovix from $21.00 to $15.00 and set a "buy" rating for the company in a research report on Thursday, February 26th. Six equities research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Enovix currently has a consensus rating of "Hold" and a consensus price target of $13.46.
Read Our Latest Analysis on Enovix
Enovix Price Performance
The company has a quick ratio of 8.13, a current ratio of 8.34 and a debt-to-equity ratio of 1.90. The company has a market cap of $1.17 billion, a price-to-earnings ratio of -7.01 and a beta of 2.16. The company has a fifty day simple moving average of $5.64 and a two-hundred day simple moving average of $8.04.
Institutional Trading of Enovix
Several large investors have recently bought and sold shares of the company. Principal Financial Group Inc. grew its holdings in Enovix by 7.6% in the third quarter. Principal Financial Group Inc. now owns 12,613 shares of the company's stock valued at $126,000 after purchasing an additional 895 shares during the last quarter. Private Advisor Group LLC grew its holdings in Enovix by 2.7% in the third quarter. Private Advisor Group LLC now owns 46,519 shares of the company's stock valued at $464,000 after purchasing an additional 1,242 shares during the last quarter. Parallel Advisors LLC grew its holdings in Enovix by 51.9% in the third quarter. Parallel Advisors LLC now owns 3,926 shares of the company's stock valued at $39,000 after purchasing an additional 1,342 shares during the last quarter. Equitable Holdings Inc. grew its holdings in Enovix by 10.9% in the third quarter. Equitable Holdings Inc. now owns 13,700 shares of the company's stock valued at $137,000 after purchasing an additional 1,342 shares during the last quarter. Finally, Avenir Corp grew its holdings in Enovix by 3.8% in the second quarter. Avenir Corp now owns 47,480 shares of the company's stock valued at $491,000 after purchasing an additional 1,730 shares during the last quarter. Institutional investors and hedge funds own 50.92% of the company's stock.
About Enovix
(
Get Free Report)
Enovix Corporation NASDAQ: ENVX develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.
Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Enovix, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enovix wasn't on the list.
While Enovix currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Click the link to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.